Sarcopenia and cachexia: molecular mechanisms and therapeutic interventions
MedComm · 2025-01 · 6 (1)
DOI: 10.1002/mco2.70030 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 05.01.2025. Verfasst von Tiantian Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology West China Hospital of Sichuan University Chengdu Sichuan China. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 933 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Sarcopenia is defined as a muscle‐wasting syndrome that occurs with accelerated aging, while cachexia is a severe wasting syndrome associated with conditions such as cancer and immunodeficiency disorders, which cannot be fully addressed through conventional nutritional supplementation. Sarcopenia can be considered a component of cachexia, with the bidirectional interplay between adipose tissue and skeletal muscle potentially serving as a molecular mechanism for both conditions. However, the underlying mechanisms differ. Recognizing the interplay and distinctions between these disorders is essential for advancing both basic and translational research in this area, enhancing diagnostic accuracy and ultimately achieving effective therapeutic solutions for affected patients. This review discusses the muscle microenvironment's changes contributing to these conditions, recent therapeutic approaches like lifestyle modifications, small molecules, and nutritional interventions, and emerging strategies such as gene editing, stem cell therapy, and gut microbiome modulation. We also address the challenges and opportunities of multimodal interventions, aiming to provide insights into the pathogenesis and molecular mechanisms of sarcopenia and cachexia, ultimately aiding in innovative strategy development and improved treatments.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology West China Hospital of Sichuan University Chengdu Sichuan China.
- Institute of Brain Science and Brain-Inspired Technology of West China Hospital Sichuan University Chengdu Sichuan China.
- Department of Neurology Chengdu Shangjin Nanfu Hospital Chengdu Sichuan China.
ORCID-Profile: Tiantian Wang
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Wang, T., Zhou, D., & Hong, Z. (2025). Sarcopenia and cachexia: molecular mechanisms and therapeutic interventions. MedComm, 6(1). https://doi.org/10.1002/mco2.70030
Vancouver
Wang T, Zhou D, Hong Z. Sarcopenia and cachexia: molecular mechanisms and therapeutic interventions. MedComm. 2025;6(1). doi:10.1002/mco2.70030
BibTeX
@article{Wang2025,
author = {Wang, Tiantian and Zhou, Dong and Hong, Zhen},
title = {Sarcopenia and cachexia: molecular mechanisms and therapeutic interventions},
journal = {MedComm},
year = {2025},
volume = {6},
number = {1},
doi = {10.1002/mco2.70030}
}
EUVIMED